AMBER VANCE: Open Payments
NPI 1558074328 · GRAY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,675 in 95 payments from 15 companies in 2025. Trend: 2023 $476 · 2024 $1,591 · 2025 $1,675
Food & beverage: $1,675
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 28 | $499 |
| ABBVIE INC. | 16 | $231 |
| Phathom Pharmaceuticals, Inc. | 14 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $155 |
| Celltrion USA Inc. | 5 | $111 |
| Gilead Sciences, Inc. | 5 | $111 |
| Ardelyx, Inc. | 4 | $87 |
| Regeneron Healthcare Solutions, Inc. | 4 | $86 |
| Aimmune Therapeutics, Inc. | 3 | $62 |
| GENZYME CORPORATION | 2 | $41 |
Products named: XIFAXAN, LINZESS, VOQUEZNA, DUPIXENT, VEGZELMA, EOHILIA, IBSRELA, ZENPEP.
Industry payments across TN — which companies pay providers there.
